Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bacillus subtilis[1] Bacillus subtilis (Bacillus subtilis)---[1] 6 💬
2Live combined bacillus subtilis and enterococcus faecium enteric-coated capsules combined with bortezomib+dexamethasone/bortezomib+dexamethasone+daratumumab/single daratumumab[3] Bortezomib,
Daratumumab,
Dexamethasone
[5] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬
[3] CD38,
NR3C1,
PSMB5 💬
[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬